Full Text View
Tabular View
No Study Results Posted
Related Studies
Belatacept Post Depletional Repopulation to Facilitate Tolerance
This study is currently recruiting participants.
Verified February 2013 by Emory University
Study NCT00565773   Information provided by Emory University

First Received on November 28, 2007.   Last Updated on February 20, 2013   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Organ Transplantation
Interventions listed in this trial
Belatacept
Alemtuzumab
donor bone marrow
Additional drug interventions recognized in this trial
Abatacept
Campath 1G
More general drug interventions related to this trial
Antineoplastic Agents
Antirheumatic Agents
Immunologic Factors
Immunosuppressive Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Sponsors listed in this trial
Emory University
Bristol-Myers Squibb
FDA Office of Orphan Products Development


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services